Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
Total Valuation
Enfusion has a market cap or net worth of $1.39B. The enterprise value is $1.22B.
Market Cap$1.39B
Enterprise Value$1.22B
Share Statistics
Enfusion has 94,802,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding94,802,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Enfusion’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 1.93%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)1.93%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee176.39K
Profits Per Employee3.43K
Employee Count1,143
Asset Turnover1.41
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Enfusion is 335.84. Enfusion’s PEG ratio is -4.14.
PE Ratio335.84
PS Ratio7.10
PB Ratio12.95
Price to Fair Value12.95
Price to FCF30.54
Price to Operating Cash Flow27.34
PEG Ratio-4.14
Income Statement
In the last 12 months, Enfusion had revenue of 201.61M and earned 2.82M in profits. Earnings per share was 0.02.
Revenue201.61M
Gross Profit136.74M
Operating Income6.16M
Pretax Income7.39M
Net Income2.82M
EBITDA6.16M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 34.68M and capital expenditures -10.89M, giving a free cash flow of 23.79M billion.
Operating Cash Flow34.68M
Free Cash Flow23.79M
Free Cash Flow per Share0.25
Dividends & Yields
Enfusion pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change14.23%
50-Day Moving Average11.08
200-Day Moving Average9.85
Relative Strength Index (RSI)42.68
Average Volume (3m)1.19M
Important Dates
Enfusion upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateMar 3, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Enfusion as a current ratio of 3.42, with Debt / Equity ratio of 27.74%
Current Ratio3.42
Quick Ratio3.42
Debt to Market Cap0.02
Net Debt to EBITDA-5.55
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Enfusion has paid 4.57M in taxes.
Income Tax4.57M
Effective Tax Rate0.62
Enterprise Valuation
Enfusion EV to EBITDA ratio is 148.48, with an EV/FCF ratio of 29.44.
EV to Sales4.53
EV to EBITDA148.48
EV to Free Cash Flow29.44
EV to Operating Cash Flow26.35
Balance Sheet
Enfusion has $54.48M in cash and marketable securities with $20.31M in debt, giving a net cash position of -$34.17M billion.
Cash & Marketable Securities$54.48M
Total Debt$20.31M
Net Cash-$34.17M
Net Cash Per Share-$0.36
Tangible Book Value Per Share$1.08
Margins
Gross margin is 67.82%, with operating margin of 3.05%, and net profit margin of 1.40%.
Gross Margin67.82%
Operating Margin3.05%
Pretax Margin3.66%
Net Profit Margin1.40%
EBITDA Margin3.05%
EBIT Margin3.05%
Analyst Forecast
The average price target for Enfusion is $11.25, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$11.25
Price Target Upside4.55% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast15.51%
EPS Growth Forecast-55.49%